Purpose: To investigate the visual outcomes and postoperative stability of IC-8 intraocular lens (AcuFocus, Inc) implantation following femtosecond laser-assisted cataract surgery.
Methods: In this prospective study, the IC-8 IOL was implanted in the non-dominant eye of 12 patients. Centration and uncorrected and corrected distance, intermediate, and near visual acuities (UDVA, UIVA, UNVA, CDVA, CIVA, CNVA) were evaluated up to postoperative month 3 (POM3). Means ± standard deviations are reported in logMAR units.
Results: There were no significant differences in absolute, vertical, and horizontal centration postoperatively versus intraoperatively. From intraoperative to POM3, mean displacement was 0.17 ± 0.09 and 0.14 ± 0.07 mm (P = .52) relative to the capsulorhexis and 0.28 ± 0.22 and 0.25 ± 0.14 mm relative to the limbus (P = .62), respectively. Centration remained within the 1.36-mm IC-8 aperture. Excluding patients with ocular comorbidities, from preoperatively to POM3, UDVA improved significantly from 0.52 ± 0.39 to 0.20 ± 0.11 logMAR (P = .024), with an efficacy index of 0.80 ± 0.31. The safety index was 1.30 ± 0.40, with no adverse events experienced. At POM3, CDVA, UIVA, and UNVA of 0.04 ± 0.05, 0.27 ± 0.11, and 0.22 ± 0.10 logMAR were achieved, respectively. Binocularly, all achieved UDVA of 20/25 or better and UIVA and UNVA of N6 and better.
Conclusions: The IC-8 IOL can attain good centration and positional stability up to POM3. It enables both extended depth of focus and tolerance to aberration, making it capable of achieving spectacle independence after surgery. [J Refract Surg. 2022;38(2):98-105.].